NATCO Pharma Limited, at its board meeting, held on February 14, 2022, Sri Sridhar Sankararaman, Non-Executive Non Independent Director of the Company has resigned from the Directorship of the company with effect from 15th February, 2022 due to his professional obligations and other pre occupations. The company also announced the re-constitution of audit Nomination and Remuneration committee as: Sri T. V. Rao, Independent Director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,057 INR | +2.38% | +5.28% | +30.16% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.16% | 2.22B | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- NATCO Pharma Limited Announces Board Changes